Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. (Q48987624)
scientific article
Language:
Current Data About Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
(P31) (Q13442814)
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

(P304) 1535-1543
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

(P407) (Q1860)

(P433) 8
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

(P478) 77
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

(P577) Monday, April 1, 1996
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

(P921) (Q180507)

(Q5452194)

(Q42824440)

(P1433) (Q326041)
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

(P1476) "Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02." (language: en)
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

(P2093) Werner-Wasik M
(P1545) 1
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

Scott CB
(P1545) 2
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

Nelson DF
(P1545) 3
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

Gaspar LE
(P1545) 4
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

Murray KJ
(P1545) 5
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

Fischbach JA
(P1545) 6
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

Nelson JS
(P1545) 7
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

Weinstein AS
(P1545) 8
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

Curran WJ Jr
(P1545) 9
(P248)
(P698) 8608540
(P813) Saturday, February 17, 2018
(P854) http://europepmc.org/abstract/MED/8608540

other details